Search filters

List of works by Catherine Sermet

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

scientific article published on 23 August 2017

Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: A time-series analysis for France 1998–2010 ⬇️

scientific article published on July 29, 2011

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

scientific article published on January 2015

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

scientific article published on 05 December 2018

Changes in osteoarthritis management by general practitioners in the COX2-inhibitor era-concomitant gastroprotective therapy

scientific article

Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications

scientific article

Cost of obesity in France

scientific article published on 27 February 2007

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

scientific article published on 14 May 2013

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs

scientific article

Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review

scientific article published on 06 June 2015

Entry time effects and follow-on drug competition

scientific article published on 12 December 2014

Factors influencing report of common mental health problems among psychologically distressed adults

scientific article published on 20 December 2013

Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population

scientific article published on 11 June 2017

Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future

article

Increased prevalence of depression, smoking, heavy drinking and use of psycho-active drugs among unemployed men in France

scientific article

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future

scientific article published on 22 July 2016

Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France

scientific article published in June 2013

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications

scientific article published in 2014

No significant decrease in antibiotic use from 1992 to 2000, in the French community

scientific article published on 8 July 2004

Ongoing pharmaceutical reforms in France: implications for key stakeholder groups

scientific article published on January 2010

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways

scientific article published on 28 September 2016

Personalizing health care: feasibility and future implications

scientific article

Policies to enhance prescribing efficiency in europe: findings and future implications

scientific article

Results per pathology. A prototype based on the year 1998

scientific article published on August 23, 2003

Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers

scientific article

Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

scientific article

Paulina is supported by:

About Paulina

Help